Prokaryotics, Inc.

Prokaryotics, Inc.

Pharmaceutical Manufacturing 1000 Morris Avenue 8 employees
Employees
8
Contacts
2
Emails
2

Prokaryotics, Inc. Overview

Headquarters
1000 Morris Avenue
Industry
Pharmaceutical Manufacturing
Employees
8
Founded
2017
Funding
2.5M
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About Prokaryotics, Inc.

Prokaryotics is a start-up biotechnology company resulting from licensing several novel antibiotic programs from Merck & Co., Inc. – by a team of former senior scientists at the company including the head of the Antimicrobial Early Discovery Unit, to optimize a number of Merck’s early-stage programs. Prokaryotics has negotiated worldwide rights to develop, manufacture and commercialize pre-clinical assets and programs targeting both Gram-negative and Gram-positive bacteria. Prokaryotics is an authentic antibacterial discovery organization committed to bringing forth innovative therapeutics to address the problem of multidrug resistant bacteria and combating the emerging global crisis of antibiotic resistance.

Prokaryotics, Inc. Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

Prokaryotics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Holly A. Sutterlin, Phd Co-founder, Chief Operating Officer
View
Pamela Demain CEO, Prokaryotics, Inc
Email
Nancy Kevin Prokaryotics
View
Sherman Tim Waddell Vice President, Chemistry
Email

Employees by Management Level

Executive 3 profiles
Senior / Lead 1 profile
Individual contributor 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 1 1 1

Compare Similar Companies to Prokaryotics, Inc.